Shares of Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) were down 2.2% on Tuesday . The company traded as low as $2.98 and last traded at $3.09, with a volume of 50,230 shares traded. The stock had previously closed at $3.16.

A number of analysts have recently weighed in on KTOV shares. Zacks Investment Research downgraded shares of Kitov Pharmaceuticals Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, June 28th. Rodman & Renshaw reaffirmed a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a research report on Monday, July 11th.

The company’s 50 day moving average is $3.07 and its 200 day moving average is $4.01. The stock’s market cap is $12.22 million.

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.